Ai Biosciences, Inc.
College Station, TX
- UEI
- J4S6VXC9CK77
- CAGE
- 6PZP9
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1902 Pinon Dr Ste C, College Station, TX 77845, USA
- Website
- aibiosciences.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i hydrogel-based bioaerosol collection cartridge for in-space environmental monitoring | Shared Services Center | $225,000 | |
| Sbir 1 a microgravity-compatible liquid-free surface sampling pen (SSP) | Shared Services Center | $156,491 | |
| Rapid RT-lamp assay for self-monitoring of acute or rebound HIV-1 infection using finger-prick whole blood sample and… | National Institute of Allergy and Infectious Diseases | $300,000 | |
| Phase II sbir "self-contained dual-mode sample preparation module using non-hazardous reagents" | Shared Services Center | $899,999 | |
| Self-contained dual-mode sample preparation module using non-hazardous reagents | Shared Services Center | $166,499 |
About Ai Biosciences, Inc.
Ai Biosciences, Inc. is a minority-owned, self-certified small disadvantaged biotechnology research company located in College Station, Texas, specializing in developing advanced diagnostic technologies, medical devices, and research tools. The company focuses on creating innovative solutions for federal agencies, with a primary emphasis on developing point-of-care molecular tests, specialized sampling technologies, and diagnostic assays for various infectious diseases and challenging environmental conditions. Their work predominantly involves Small Business Innovation Research (SBIR) contracts and grants, targeting critical areas such as HIV detection, surface sampling in microgravity, and rapid pathogen identification.
Through federal contract awards, Ai Biosciences, Inc. has consistently secured SBIR Phase I and Phase II contracts from agencies including the Shared Services Center, National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), NASA, and the CDC. Their contract work encompasses developing specialized technologies such as a microgravity-compatible liquid-free surface sampling pen, a rapid reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for HIV-1 infection monitoring, and a self-contained dual-mode sample preparation module using non-hazardous reagents. These contracts are predominantly set aside for small businesses, reflecting the company's status as a minority-owned, small disadvantaged business. The contract values range from $156,491 to $899,999, demonstrating the company's capability to secure substantial federal research and development funding.
Ai Biosciences, Inc. has also been awarded federal grants focusing on developing rapid point-of-care molecular diagnostic technologies. Their grant work includes projects funded by the Office of the Director and the National Institute of Allergy and Infectious Diseases, targeting critical areas such as developing a rapid point-of-care molecular test for SARS-CoV-2 and influenza A/B, and creating an ultrasensitive, low-cost P24 antigen test for early HIV detection. These grants, ranging from formula grants to project grants, align with broader public health initiatives like the federal "Ending the HIV Epidemic: A Plan for America" initiative. The grants emphasize developing accessible, accurate diagnostic technologies that can be used in decentralized settings, particularly in areas with limited infrastructure and laboratory capabilities.
Quick answers
What is Ai Biosciences, Inc.'s UEI?
Ai Biosciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is J4S6VXC9CK77.
What is Ai Biosciences, Inc.'s CAGE code?
Ai Biosciences, Inc.'s CAGE code is 6PZP9.
What is Ai Biosciences, Inc.'s primary NAICS code?
Ai Biosciences, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Ai Biosciences, Inc. located?
Ai Biosciences, Inc.'s physical address in SAM.gov is 1902 Pinon Dr Ste C, College Station, TX 77845, USA.
Is Ai Biosciences, Inc. registered in SAM.gov?
Yes. Ai Biosciences, Inc.'s SAM.gov registration is active through May 22, 2027.
What is Ai Biosciences, Inc.'s most recent federal award?
Ai Biosciences, Inc.'s most recent federal contract award is Sbir phase i hydrogel-based bioaerosol collection cartridge for in-space environmental monitoring (80NSSC26C0194), from Shared Services Center, on September 30, 2026.
On GovTribe
See Ai Biosciences, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors